Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2016

LITTLE FALLS, N.J., Dec. 1, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMN) will release the results for its first quarter ended October 31, 2016 on Thursday, December 8 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.

To participate in the conference call, dial 1-877-407-8033 (US & Canada) or 1-201-689-8033 (International) approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, December 8, 2016 through midnight on February 8, 2017 by dialing 1-877-481-4010 (US & Canada) or 1-919-882-2331 (International) and using conference ID #:10164.

An audio webcast will be available via the Cantel website at www.cantelmedical.com. A replay of the presentation will be archived on the Cantel web site for those unable to listen live.

About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at www.cantelmedical.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-hold-conference-call-to-discuss-results-for-its-first-quarter-ended-october-31-2016-300371250.html

SOURCE Cantel Medical Corp.